DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn’s and Colitis Organisation study
Uri Kopylov(Sheba Medical Center), Marc Ferrante(Universitair Ziekenhuis Leuven), Nikolaos Kamperidis(St Mark's Hospital), Xavier Roblin(Centre Hospitalier Universitaire de Saint-Étienne), E I Tsoukal(Evangelismos Hospital), Gionata Fiorino(Carlo Forlanini Hospital), Ariella Bar‐Gil Shitrit, Taina Sipponen(University of Helsinki), Dimitrios Christodoulou(University of Ioannina), Naila Arebi, Peter Bossuyt(Imelda Hospital), Irit Avni‐Biron, Christian Maaser(Klinikum Lüneburg), Iris Dotan(Tel Aviv University), Britta Siegmund(Humboldt-Universität zu Berlin), Torsten Kucharzik(Klinikum Lüneburg), Luc Biedermann(University of Zurich), Bram Verstockt(Universitair Ziekenhuis Leuven), Laurent Peyrin‐Biroulet(Délégation Centre-Est), P Steinhagen(Humboldt-Universität zu Berlin), Shaji Sebastian(University of Hull), Alessandro Armuzzi, DC Baumgart(Radboud University Nijmegen), Tim Raine(National Health Service), Shomron Ben‐Horin(Tel Aviv University), Bella Ungar(Sheba Medical Center), Henit Yanai(Tel Aviv University), Sandro Ardizzone(European CanCer Organisation), Marina Coletta(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Daniela Pugliese(Agostino Gemelli University Polyclinic), Mariangela Allocca(Vita-Salute San Raffaele University), Nitsan Maharshak(Yale University), Elena Sonnenberg(Charité - Universitätsmedizin Berlin), Gerasimos Mantzaris(Evangelismos Hospital), Rami Eliakim(Sheba Medical Center), Yulia Ron(Tel Aviv University), K.H. Katsanos, Pauliina Molander(University of Helsinki)
Cited by 4
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k